Figure 5. Effect of shRNA treatment on corneal NV. Representative pictures depicting corneal NV in normal and control eyes (A, B) and in eyes receiving subconjunctival injections of saline (C), nonspecific shRNA (Vehicle- RNAi; D) or HIF-1α specific (RNAi-A; E) at day 10 after CL wear.